Microbial Diseases of the Respiratory System: Structure, Defense, and Pathogenesis

Microbial Diseases of the Respiratory System

Overview of the Respiratory System

The respiratory system is divided into upper and lower regions, each with distinct anatomical structures and defense mechanisms against microbial invasion. Understanding these divisions is essential for recognizing how pathogens cause disease and how the body responds.

• Upper respiratory system: Includes the nose, pharynx, middle ear, and eustachian tubes. Saliva and tears help protect mucosal surfaces.

• Lower respiratory system: Comprises the larynx, trachea, bronchial tubes, and alveoli. The ciliary escalator moves particles toward the throat, alveolar macrophages destroy microorganisms, and respiratory mucus protects mucosal surfaces.

Defense Mechanisms of the Respiratory System

The respiratory tract employs several innate defenses to prevent microbial entry and colonization:

• Ciliary escalator: Ciliated epithelial cells move mucus and trapped particles upward toward the throat.

• Alveolar macrophages: Engulf and destroy microorganisms in the alveoli.

• Mucus: Traps pathogens and contains antimicrobial substances.

• Normal microbiota: Compete with pathogens for nutrients and produce inhibitory substances, especially in the upper respiratory tract. The lower respiratory tract is nearly sterile.

Microbial Diseases of the Upper Respiratory System

Common Diseases and Their Characteristics

Several diseases affect the upper respiratory tract, most of which are self-limiting. However, some can be life-threatening, especially in vulnerable populations.

• Pharyngitis: Inflammation of the throat (sore throat).

• Laryngitis: Inflammation of the larynx (voice box).

• Tonsillitis: Inflammation of the tonsils.

• Sinusitis: Inflammation of the sinuses.

• Epiglottitis: Inflammation of the epiglottis, often caused by Haemophilus influenzae type b; can be life-threatening.

Bacterial Diseases of the Upper Respiratory System

Several bacterial pathogens cause significant diseases in the upper respiratory tract. Laboratory identification and appropriate treatment are crucial for management.

• Streptococcal pharyngitis (strep throat): Caused by group A streptococci (Streptococcus pyogenes), which are resistant to phagocytosis and produce streptokinases and streptolysins. Symptoms include local inflammation, fever, tonsillitis, and enlarged lymph nodes. Diagnosis is by throat culture or rapid antigen detection tests.

• Scarlet fever: Caused by erythrogenic toxin-producing strains of S. pyogenes. Characterized by a red rash and peeling skin.

• Diphtheria: Caused by Corynebacterium diphtheriae (Gram-positive rod). Forms a tough grayish membrane in the throat, which can block air passage. The exotoxin can damage the heart and kidneys. Treated with antibiotics and antitoxin; prevented by the DTaP vaccine.

• Otitis media: Infection of the middle ear, often caused by Streptococcus pneumoniae, nonencapsulated H. influenzae, Moraxella catarrhalis, S. pyogenes, or respiratory syncytial viruses. Common in children due to smaller auditory tubes. Treated with broad-spectrum penicillins.

Viral Diseases of the Upper Respiratory System

The common cold is the most prevalent viral disease of the upper respiratory tract, caused by over 200 different viruses, including rhinoviruses, coronaviruses, adenoviruses, and enteroviruses.

• Symptoms: Sneezing, nasal secretion, congestion, sometimes leading to laryngitis and otitis media. Fever is uncommon.

• Treatment: Supportive care; antibiotics are ineffective.

Microbial Diseases of the Lower Respiratory System

Overview and Common Diseases

The lower respiratory tract can be affected by a variety of pathogens, leading to diseases such as bronchitis, bronchiolitis, and pneumonia. Pulmonary alveoli involvement is characteristic of pneumonia.

Bacterial Diseases of the Lower Respiratory System

Pertussis (Whooping Cough)

Pertussis is caused by Bordetella pertussis, a Gram-negative coccobacillus that produces a capsule for attachment to ciliated cells in the trachea. The tracheal cytotoxin damages ciliated cells, and the pertussis toxin causes systemic symptoms.

• Stages:

  • Catarrhal stage: Resembles the common cold.

  • Paroxysmal stage: Violent coughing and gasping for air (1–6 weeks).

  • Convalescence stage: Recovery, may last for months.

• Prevention: DTaP vaccine.

• Treatment: Erythromycin or other macrolides.

Tuberculosis

Tuberculosis (TB) is caused primarily by Mycobacterium tuberculosis, an acid-fast, obligate aerobe with a lipid-rich cell wall. The pathogen is resistant to drying and antimicrobials, and can remain dormant in the host for years.

• Pathogenesis: Inhaled organisms are phagocytized by alveolar macrophages. Mycolic acids in the cell wall stimulate an inflammatory response, leading to the formation of tubercles. If the immune response is inadequate, the tubercle breaks down, releasing bacteria and causing miliary TB.

• Diagnosis: Tuberculin skin test (Mantoux test), chest x-ray or CT, acid-fast staining, culture, and nucleic acid amplification tests (NAAT).

• Treatment: Minimum of 6 months with first-line drugs (isoniazid, rifampin, ethambutol, pyrazinamide). MDR and XDR strains require second-line drugs.

• Prevention: BCG vaccine (live, attenuated M. bovis), not widely used in the U.S.

Bacterial Pneumonias

Pneumonia is classified based on the causative agent and the anatomical location of infection.

• Typical pneumonia: Caused by Streptococcus pneumoniae (encapsulated, Gram-positive diplococci). Diagnosed by optochin-inhibition test, bile solubility test, or detection of capsular antigen in urine. Treated with macrolides; prevented by conjugated pneumococcal vaccine.

• Healthcare-associated pneumonia: Often caused by Staphylococcus aureus.

• Atypical pneumonia: Caused by organisms such as Mycoplasma pneumoniae (no cell wall, "fried-egg" appearance on media, diagnosed by PCR, treated with tetracyclines), Legionella pneumophila (grows in water systems, treated with azithromycin), and Chlamydia pneumoniae (mild illness, treated with azithromycin).

• Other agents: Haemophilus influenzae (treated with cephalosporins), Coxiella burnetii (Q fever, treated with doxycycline), Burkholderia pseudomallei (melioidosis, treated with ceftazidime).

Viral Diseases of the Lower Respiratory System

Major viral pathogens affecting the lower respiratory tract include:

• Viral pneumonia: Often a complication of influenza, measles, or chickenpox. Coronaviruses (SARS, MERS, SARS-CoV-2) have emerged as significant causes.

• COVID-19: Caused by SARS-CoV-2, a Betacoronavirus. Symptoms range from mild to severe, with risks for older adults and those with comorbidities. Transmission is primarily airborne. Diagnosed by rapid antigen tests or PCR. Treated with antivirals (remdesivir, Paxlovid, molnupiravir) and convalescent plasma. Vaccines include mRNA, virus-vector, and subunit types.

• Respiratory Syncytial Virus (RSV): Most common viral respiratory disease in infants. Causes cell fusion (syncytium) in culture. Treated with palivizumab; vaccines are under development.

• Influenza: Caused by Influenzavirus (A, B, C). Characterized by chills, fever, headache, and muscle aches. Diagnosed by rapid antigen tests or PCR. Treated with neuraminidase inhibitors (zanamivir, oseltamivir). Annual multivalent vaccines are available.

Fungal Diseases of the Lower Respiratory System

Major fungal pathogens can cause severe respiratory disease, especially in immunocompromised individuals.

• Histoplasmosis: Caused by Histoplasma capsulatum, a dimorphic fungus. Acquired from airborne conidia in areas with bird or bat droppings. Treated with itraconazole.

• Coccidioidomycosis (Valley fever): Caused by Coccidioides immitis, a dimorphic fungus found in desert soils. Treated with fluconazole or itraconazole.

• Pneumocystis pneumonia (PCP): Caused by Pneumocystis jirovecii, a yeastlike fungus. Primary indicator of AIDS. Treated with trimethoprim-sulfamethoxazole.

• Blastomycosis: Caused by Blastomyces dermatitidis, a dimorphic fungus. Treated with itraconazole and amphotericin B.

• Other fungi: Aspergillus fumigatus (aspergillosis), Rhizopus, and Mucor can cause respiratory disease, especially in immunocompromised individuals.

Summary Table: Selected Respiratory Diseases

This table summarizes key features of selected respiratory diseases, including causative agents, symptoms, diagnosis, and treatment/prevention.

Disease	Pathogen	Signs and Symptoms	Diagnosis	Treatment/Prevention
Streptococcal Pharyngitis	Streptococcus pyogenes	Sore throat, fever, tonsillitis	Throat culture, rapid antigen test	Penicillin
Diphtheria	Corynebacterium diphtheriae	Grayish throat membrane, fever	Culture, clinical presentation	Antibiotics + antitoxin, DTaP vaccine
Pneumococcal Pneumonia	Streptococcus pneumoniae	Fever, chest pain, difficulty breathing	Optochin test, urine antigen	Macrolides, vaccine
COVID-19	SARS-CoV-2	Fever, cough, loss of smell/taste	PCR, antigen test	Antivirals, vaccines
Histoplasmosis	Histoplasma capsulatum	Lung lesions, TB-like symptoms	Serology	Itraconazole

Additional info: This summary includes expanded academic context and logical grouping of fragmented topics for clarity and completeness. For more detailed mechanisms, refer to the referenced textbook chapters and laboratory manuals.